GSK, Clover part ways on COVID-19 vaccine, putting Dynavax in the spotlight
First, lackluster data forced GlaxoSmithKline and partner Sanofi back to the drawing board with their COVID-19 shot. Now, another would-be vaccine partner has decided to
Clover picks Dynavax adjuvant over GlaxoSmithKline’s for late-stage coronavirus vaccine testing
First, lackluster data forced GlaxoSmithKline and partner Sanofi back to the drawing board with their COVID-19 shot. Now, another would-be vaccine partner has decided to
Lilly drives more access to COVID-19 antibodies with new infusion centers
Eli Lilly’s COVID-19 monoclonal antibody isn’t getting as much use as it could, thanks to logistical hurdles. So the drugmaker is taking matters into its
Teva, Mylan and fellow valsartan makers have to face consumer fraud claims: judge
A New Jersey federal judge on Friday tossed out consumers’ fraud claims against distributors of generic valsartan blood pressure drugs but waved through allegations against manufacturers themselves.
Vaccine manufacturing greenhorn Bayer to make 160M doses of CureVac’s COVID-19 shot
In its nearly 160-year history, Bayer has never produced vaccines for humans. But the COVID-19 pandemic is changing that. As part of a recently penned
While Pfizer and Moderna hold the lead, new data from J&J, Novavax show there’s ‘room for everyone’ in the market: analysts
With Novavax and Johnson & Johnson data now in hand, the world has efficacy numbers on at least five COVID-19 vaccine programs. That’s plenty for
Millions could benefit from genetic screening before prescribing, new research finds
New research has found that millions of patients could benefit from genetic screening before being prescribed common medicines. The research, led by the University of
NHS has offered COVID-19 vaccine to all eligible care homes in England
The NHS has now offered COVID-19 vaccinations to residents at all eligible care homes in England, according to official figures. In a statement, the health
Kesimpta and Vazkepa among latest CHMP recommendations
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended 13 new medicines for approval in its latest meeting. This
EU authorisation for AstraZeneca’s COVID-19 vaccine
AstraZeneca’s Oxford University-partnered COVID-19 vaccine has scored a conditional marketing authorisation (CMA) for use in the EU for the prevention of COVID-19 in individuals aged